Beam Therapeutics (BEAM) Research & Development (2019 - 2025)
Historic Research & Development for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to $109.8 million.
- Beam Therapeutics' Research & Development rose 1645.59% to $109.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $411.8 million, marking a year-over-year increase of 137.69%. This contributed to the annual value of $367.6 million for FY2024, which is 1596.32% down from last year.
- Latest data reveals that Beam Therapeutics reported Research & Development of $109.8 million as of Q3 2025, which was up 1645.59% from $101.8 million recorded in Q2 2025.
- In the past 5 years, Beam Therapeutics' Research & Development registered a high of $190.1 million during Q1 2021, and its lowest value of $45.6 million during Q2 2021.
- Moreover, its 5-year median value for Research & Development was $96.8 million (2021), whereas its average is $95.5 million.
- Its Research & Development has fluctuated over the past 5 years, first soared by 78220.34% in 2021, then crashed by 6559.29% in 2022.
- Beam Therapeutics' Research & Development (Quarter) stood at $96.8 million in 2021, then dropped by 10.79% to $86.3 million in 2022, then skyrocketed by 62.24% to $140.1 million in 2023, then dropped by 27.58% to $101.4 million in 2024, then grew by 8.21% to $109.8 million in 2025.
- Its Research & Development stands at $109.8 million for Q3 2025, versus $101.8 million for Q2 2025 and $98.8 million for Q1 2025.